| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |